Lung function in patients with asthma in the post-COVID period
https://doi.org/10.36604/1998-5029-2024-93-72-82
Abstract
Aim. To assess the lung function in patients with bronchial asthma (BA) after new-onset coronavirus infection.
Materials and methods. Fifty-five patients who underwent COVID-19 participated in the study under conditions of voluntary informed consent. The main group consisted of 30 patients with mild BA, the comparison group – 25 patients without chronic respiratory diseases (CRD). According to chest computed tomography (CT) findings, the degree of lung parenchyma involvement was classified as follows: mild COVID-19 (CT 0 stage) in 14 patients; moderate COVID-19 (CT 1-2 stages) in 27 patients; and severe COVID-19 (CT 3-4 stages) in 14 patients. Lung function tests were conducted once, adhering to both Russian and international standards.
Results. In patients with BA, obstructive pulmonary function impairment was predominant at CT 1-2 stages (79%), CT 0 stage (67%), and CT 3-4 stages (43%). Lung diffusion capacity (LDC) was impaired predominantly in CT 3-4 stages in both BA patients and those without CRD, occurring in 57% of cases. Analysis of lung function showed that LDC reduction was detected in 17% of BA cases and 24% of non-CRD cases. There were no statistically significant changes in pulmonary ventilation among BA patients with impaired LDC compared to patients without CRD.
Conclusion. All patients with respiratory symptoms after COVID-19 should undergo comprehensive lung function assessment to identify bronchial obstruction, impaired lung diffusion capacity, and ensure timely intervention.
About the Authors
E. E. MineevaRussian Federation
Elena E. Mineeva, MD, PhD (Med.), Staff Scientist, Laboratory of Rehabilitative Treatment, Vladivostok Branch of Far Eastern Scientific Center of Physiology
73g Russkaya Str., Vladivostok, 690105
M. V. Antonyuk
Russian Federation
Marina V. Antonyuk, MD, PhD, DSc (Med.), Professor, Head of Laboratory of Rehabilitative Treatment
73g Russkaya Str., Vladivostok, 690105
A. V. Yurenko
Russian Federation
Alla V. Yurenko, MD, PhD (Med.), Senior Staff Scientist, Laboratory of Rehabilitative Treatment
73g Russkaya Str., Vladivostok, 690105
References
1. Badalyan K.R., Solov′yeva E.Yu. [COVID-19: long-term health impacts]. Consilium Medicum 2021; 23(12):993–999 (in Russian). https://doi.org/10.26442/20751753.2021.12.201347
2. Pogosova N.V., Paleyev F.N., Ausheva A.K., Kuchiyev D.T., Gaman S.A., Veselova T.N., Bel′kind M.B., Sokolova O.YU., Zhetisheva R.A., Ternovoy S.K., Boytsov S.A. [Sequelae of COVID-19 at long-term follow-up after hospitalization]. Ratsional'naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology 2022; 18(2):118–126 (in Russian). https://doi.org/10.20996/1819-6446-2022-04-03
3. Zaytsev A.A., Leshchenko I.V. [Ongoing symptomatic COVID-19 – practical advice: A review]. Consilium Medicum 2022; 24(3):209–212 (in Russian). https://doi.org/10.26442/20751753.2022.3.201531
4. Lee J.H., Yim J.J., Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir. Res. 2022; 23(1):233. https://doi.org/10.1186/s12931-022-02163-x
5. Ezhov M.V., Popova M.D., Alekseyeva I.A., Pokrovskiy N.S., Paleyev F.N. [Novel coronavirus infection: from pathogenesis to therapy]. Kardiologicheskiy vestnik = Russian Cardiology Bulletin 2021; 16(1):10–19 (in Russian) https://doi.org/10.17116/Cardiobulletin20211601110
6. Leshchenko I.V., Esaulova N.A., Glushkova T.V., Skornyakov S.N. [Respiratory disorders of post-COVID-19 syndrome]. Terapevticheskiy arkhiv 2023; 95(3):203–209 (in Russian). https://doi.org/10.26442/00403660.2023.03.202072
7. Zolotnitskaya V.P., Speranskaya A.A., Kuzubova N.A., Titova O.N., Amosova O.V. [Long-term effects of COVID-19 in patients according to the functional lung imaging in radiation therapy]. Russkii meditsinskii zhurnal. Meditsinskoye obozreniye = Russian medical inquiry 2022; 6(7):360–366 (in Russian). https://doi.org/10.32364/2587-6821-2022-6-7-360-366
8. Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021; 9(2):129. https://doi.org/10.1016/S2213-2600(21)00031-X
9. [Temporary methodological recommendations "Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19), version 18"] (26.1.2023) (in Russian). Available at: BMP_ COVID-19_V18.pdf
10. Thomas M., Price O.J., Hull J.H. Pulmonary function and COVID-19. Curr. Opin. Physiol. 2021; 21:29–35. https://doi.org/ 10.1016/j.cophys.2021.03.005
11. Ovsyannikov YE.S., Avdeyev S.N., Budnevskiy A.V., Drobysheva YE.S., Savushkina I.A. [Bronchial Asthma and COVID-19: comorbidity issues]. Tuberkulez i bolezni legkikh = Tuberculesis and lung diseases 2021; 99(9):6–14 (in Russian). https://doi.org/10.21292/2075-1230-2021-99-9-6-14
12. Trukhan D.I. [New coronavirus infection (COVID-19) and respiratory diseases / pathological conditions]. Meditsinskiy sovet = Medical Council 2022; 16(18):154–161 (in Russian). https://doi.org/10.21518/2079-701X-2022-16-18-154-161
13. Alekperov R.I., Makar'yants N.N., Chushkin M.I., Abubikirov A.F., Kravchenko N.Yu. [Bronchial Asthma and COVID-19]. Prakticheskaya pul'monologiya = The Journal of Practical Pulmonology 2023; 2:25–32 (in Russian). https://doi.org/10.24412/2409-6636-2023-12875
14. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (2023 update). Available at: https://ginasthma.org/wp-content/uploads/2023/07/GINA-2023-Full-report-23_07_06-WMS.pdf
15. Juniper E.F., Bousquet J., Abetz L., Bateman E.D. GOAL Committee. Identifying ‘well-controlled’ and ‘not wellcontrolled’ asthma using the Asthma Control Questionnaire. Respir. Med. 2006; 100(4):616–621. https://doi.org/10.1016/j.rmed.2005.08.012
16. Kameneva M.Yu., Chernyak A.V., Aysanov Z.R., Avdeyev S.N., Babak S.L., Belevskiy A.S., Beresten' N.F., Kalmanova Ye.N., Malyavin A.G., Perel'man Yu.M., Prikhod'ko A.G., Struchkov P.V., Chikina S.Yu., Chushkin M.I. [Spirometry: national guidelines for the testing and interpretation of results Interregional Public Organization «Russian Respiratory Society» All-Russian Public Organization «Russian Association of Specialists in Functional Diagnostics» All- Russian Public Organization «Russian Scientific Medical Society of Therapists»]. Pul'monologiya = Russian Pulmonology 2023; 33(3):307–340 (in Russian). https://doi.org/10.18093/08690189-2023-33-3-307-340
17. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., Crapo R., Enright P., van der Grinten C.P., Gustafsson P., Jensen R., Johnson D.C, MacIntyre N., McKay R., Navajas D., Pedersen O.F., Pellegrino R., Viegi G., Wanger J. Standardisation of spirometry. Eur. Respir. J. 2005; 26(2):319–337. https://doi.org/10.1183/09031936.05.00034805
18. Quanjer P.H., Stanojevic S., Cole T.J., Baur X., Hall G.L., Culver B.H., Enrigh P.L., Hankinson J.L., Ip M.S.M., Zheng J., Stocks J. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 2012; 40(10):1324–1343. https://doi.org/10.1183/09031936.00080312
19. Aysanov Z.R., Kalmanova Ye.N., Kameneva M.Yu., Kiryukhina L.D., Lukina O.F., Naumenko Zh.K., Neklyudova G.V., Perel'man YU.M., Savushkina O.I., Struchkov P.V., Chernyak A.V., Chushkin M.I., Shergina Ye.A. [Recommendations of the Russian Respiratory Society on conducting functional studies of the respiratory system during the COVID-19 pandemic. Version 1.1. 19.05.2020]. Prakticheskaya pul'monologiya 2020; 1:104–107 (in Russian).
20. Stanojevic S., Graham B.L., Cooper B.G., Bruce R., Thompson B.R., Carter K.W., Francis R.W., Graham L., Hall G.L. Global Lung Function Initiative (GLI) TLCO working group. Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur. Respir. J. 2017; 50(3):1700010. https://doi.org/10.1183/13993003.00010-2017
21. Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk factors associated with post-COVID-19 condition systematic review and meta-analysis. JAMA Intern. Med. 2023; 183(6):566–580. https://doi.org/10.1001/jamainternmed.2023.0750
22. Maglietta G., Diodati F., Puntoni M., Lazzarelli S., Marcomini B., Patrizi L., Caminiti C. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J. Clin. Med. 2022; 11(6):1541. https://doi.org/10.3390/jcm11061541
23. Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mulè G., Augello M., Mondatore D., Allegrini M., Cona A., Tesoro D., Tagliaferri G., Viganò O., Suardi E., Tincati C., Beringheli T., Varisco B., Battistini C.L., Piscopo K., Vegni E., Tavelli A., Terzoni S., Marchetti G., Monforte A.D. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin. Microbiol. Infect. 2022; 28(4):611.e9–e16. https://doi.org/10.1016/j.cmi.2021.11.002
24. Florencio L.L., Fernández-de-Las-Peñas C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir. Med. 2022; 10(8):726–727. https://doi.org/10.1016/S2213-2600(22)00159-X
25. Antoniou K.M., Vasarmidi E., Russell A.M., Andrejak C., Crestani B., Delcroix M., Dinh-Xuan A.T., Poletti V., Sverzellati N., Vitacca M., Witzenrath M., Tonia T., Spanevello A. European Respiratory Society statement on long COVID follow-up. Eur Respir. J. 2022; 60(2):2102174. https://doi.org/10.1183/13993003.02174-2021
26. Steinbeis F., Thibeault C., Doellinger F., Ring R.M., Mittermaier M., Ruwwe-Glösenkamp C., Alius F., Knape P., Meyer H.J., Lippert L.J., Helbig E.T., Grund D., Temmesfeld-Wollbrück B., Suttorp N., Sander L.E., Kurth F., Penzkofer T., Witzenrath M., Zoller T. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respir. Med. 2022; 191:106709. https://doi.org/10.1016/j.rmed.2021.106709
Review
For citations:
Mineeva E.E., Antonyuk M.V., Yurenko A.V. Lung function in patients with asthma in the post-COVID period. Bulletin Physiology and Pathology of Respiration. 2024;(93):72-82. (In Russ.) https://doi.org/10.36604/1998-5029-2024-93-72-82